Nektar Therapeutics NKTR Enterprise value

Enterprise value at other companies

AmgenAMGN

$252.17B+23.1%

Regeneron PharmaceuticalsREGN

$65.61B+15.0%

ImmunityBio, Inc.IBRX

$8.16B+187%

Apogee Therapeutics, Inc.APGE

$5.84B+181%

Artiva Biotherapeutics, Inc.ARTV

$179.24M+662%

Vera TherapeuticsVERA

$2.83B+85.0%

FAQ

What is Nektar Therapeutics's enterprise value?

Nektar Therapeutics (NKTR) reported enterprise value of $2.14B in Q1 2026.

How has Nektar Therapeutics's enterprise value changed year-over-year?

Nektar Therapeutics's enterprise value increased by 874.5% year-over-year, from $219.76M to $2.14B.

What is the long-term trend for Nektar Therapeutics's enterprise value?

Over 5 years (2020 to 2025), Nektar Therapeutics's enterprise value has grown at a -22.1% compound annual growth rate (CAGR), from $3.28B to $942.6M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.